Amgen Europe B.V. (labeling, secondary packaging and batch release)
UkraineAll drugs from this manufacturer
-
The drug is used to treat symptomatic anemia in adults and children with chronic kidney disease, as well as in adult cancer patients undergoing chemotherapy.
Dosage form: solution for injection
Active substance Dosage darbepoetin alfa 25 mcg/ml ATC: B03XA02
-
The drug is used to treat symptomatic anemia in adults and children with chronic renal failure, as well as in adult cancer patients undergoing chemotherapy.
Dosage form: solution for injection
Active substance Dosage darbepoetin alfa 100 mcg/ml ATC: B03XA02
-
The drug is used to treat symptomatic anemia in adults and children with chronic kidney disease, as well as in adult cancer patients receiving chemotherapy.
Dosage form: solution for injection
Active substance Dosage darbepoetin alfa 500 mcg/ml ATC: B03XA02
-
The drug is prescribed to adults for the treatment of metastatic colorectal cancer, provided that the tumor has a non-mutant (wild-type) RAS gene.
Dosage form: concentrate for infusion solution
Active substance Dosage panitumumab 20 mg/ml ATC: L01FE02